Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04684927

PMS Evaluation of Safety and Efficacy of the MID-C System 5 Years Post-implantation in AIS

Post-approval Study to Evaluate the Continued Safety and Efficacy of the MID-C System 5 Years Post-implantation in Adolescent Idiopathic Scoliosis (AIS)

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Apifix · Industry
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The ApiFix MID-C System is a unidirectional expandable rod, designed to be connected unilaterally to the spine via 2 anchor points on the concave side of a scoliotic deformity above and below the apex of the major curvature to treat adolescent idiopathic scoliosis. The MID-C System is designed to act as an internal brace. A total of 10 patients, who are planned to undrego the MID-C System implantation procedure will be enrolled for the study. A 5 years follow-up post surgery will be performed for these patients in order to evaluate the long term safety and efficacy of the MID-C System.

Conditions

Interventions

TypeNameDescription
DEVICEMID-C System -Minimal invasive deformity correction system for the treatment of AISA 5 years follow-up will be performed for all patients who underwent AIS repair surgery using the MID-C System. The follow-up in order to assess safety and efficacy measurments. Eligible Patients will be followed and assessed at the following time points: Immediate Post-op up to 6 weeks, 6 months, 12 months, and then annually out to 5 years post-implantation. During the study, the following rating scales and assessments will be conducted to assess the probable benefit and safety of the treatment: Physical exam,X-rays,Cobb angle measurements,Adverse Events (AEs) and Scoliosis research society (SRS-22) questionnaire: The questionnaire is commonly used to assess health related quality of life in children with AIS.

Timeline

Start date
2021-01-20
Primary completion
2028-01-20
Completion
2028-03-20
First posted
2020-12-28
Last updated
2021-03-10

Source: ClinicalTrials.gov record NCT04684927. Inclusion in this directory is not an endorsement.